Functional p53 determines docetaxel sensitivity in prostate cancer cells.

Liu, Chengfei; Zhu, Yezi; Lou, Wei; Nadiminty, Nagalakshmi; Chen, Xinbin; Zhou, Qinghua; Shi, Xu Bao; deVere White, Ralph W; Gao, Allen C

Liu, Chengfei; Zhu, Yezi; Lou, Wei; Nadiminty, Nagalakshmi; Chen, Xinbin; Zhou, Qinghua; Shi, Xu Bao; deVere White, Ralph W; Gao, Allen C.

Affiliation

Liu C; Department of Urology, University of California at Davis, Sacramento, California 95817, USA.

Prostate ; 73(4): 418-27, 2013 Mar.

Article in En | MEDLINE | ID: mdl-22996738

Subject(s)

Antineoplastic Agents/pharmacology; Genes, p53/physiology; Prostatic Neoplasms/genetics; Taxoids/pharmacology; Antineoplastic Agents/therapeutic use; Apoptosis/drug effects; Apoptosis/physiology; Cell Line, Tumor; Cell Proliferation/drug effects; Docetaxel; Genes, p53/drug effects; Humans; Male; Phosphorylation/drug effects; Prostatic Neoplasms/drug therapy; Prostatic Neoplasms/pathology; Taxoids/therapeutic use

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Genes, p53 / Taxoids / Antineoplastic Agents Type of study: Diagnostic_studies Limits: Humans / Male Language: En Journal: Prostate Year: 2013 Document type: Article Affiliation country: United States Country of publication: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google